173 related articles for article (PubMed ID: 33301214)
1. Guanylate-binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients.
Wan Q; Qu J; Li L; Gao F
J Clin Lab Anal; 2021 Feb; 35(2):e23610. PubMed ID: 33301214
[TBL] [Abstract][Full Text] [Related]
2. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
3. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients.
Ye Q; Zhang M; Yin Y
J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
5. Discohesive growth pattern (Disco-p) as an unfavorable prognostic factor in lung adenocarcinoma: an analysis of 1062 Japanese patients with resected lung adenocarcinoma.
Rokutan-Kurata M; Yoshizawa A; Nakajima N; Teramoto Y; Sumiyoshi S; Kondo K; Hamaji M; Sonobe M; Menju T; Date H; Haga H
Mod Pathol; 2020 Sep; 33(9):1722-1731. PubMed ID: 32313186
[TBL] [Abstract][Full Text] [Related]
6. Correlation of PADI4, GBP1, miR-215, and TMB Expression Levels with Clinical Characteristics and Prognosis of Lung Cancer.
Chen J; Han Y; Zhao Y; Zhu W
Altern Ther Health Med; 2023 Jul; 29(5):238-241. PubMed ID: 37052970
[TBL] [Abstract][Full Text] [Related]
7. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
Liu Y; Tian J; Qin D; Liu J; Xie Y
J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
[TBL] [Abstract][Full Text] [Related]
8. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
9. Guanylate-binding protein 1 (GBP1) promotes lymph node metastasis in human esophageal squamous cell carcinoma.
Li L; Ma G; Jing C; Liu Z
Discov Med; 2015 Dec; 20(112):369-78. PubMed ID: 26760981
[TBL] [Abstract][Full Text] [Related]
10. Correlated low IGF2BP1 and FOXM1 expression predicts a good prognosis in lung adenocarcinoma.
Huang H; Wang D; Guo W; Zhuang X; He Y
Pathol Res Pract; 2019 Jul; 215(7):152433. PubMed ID: 31085008
[TBL] [Abstract][Full Text] [Related]
11. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
[TBL] [Abstract][Full Text] [Related]
12. Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients.
Liu S; Li Y; Qi W; Zhao Y; Huang A; Sheng W; Lei B; Lin P; Zhu H; Li W; Shen H
Diagn Pathol; 2014 Mar; 9():69. PubMed ID: 24661909
[TBL] [Abstract][Full Text] [Related]
13. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Zhu C; Jiang L; Xu J; Ren A; Ju F; Shu Y
Pathol Res Pract; 2020 Apr; 216(4):152885. PubMed ID: 32113794
[TBL] [Abstract][Full Text] [Related]
15. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
Chen H; Yan S; Dong L; Li X
J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
[TBL] [Abstract][Full Text] [Related]
16. Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.
Li L; Xu B; Zhang H; Wu J; Song Q; Yu J
J Clin Lab Anal; 2020 Jan; 34(1):e23031. PubMed ID: 31713908
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
18. GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer.
Cheng L; Gou L; Wei T; Zhang J
Int J Oncol; 2020 Sep; 57(3):858-870. PubMed ID: 32582960
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
20. P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinoma.
Chen XK; Gu CL; Fan JQ; Zhang XM
Biomed Pharmacother; 2020 May; 125():109871. PubMed ID: 32187953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]